Protonitazene is a highly potent synthetic opioid that has increasingly appeared in the illicit drug supply. It belongs to a group of substances called nitazenes, which were originally studied as possible pain medications but were never approved for medical use in the United States.
Although protonitazene remains less familiar to the public than fentanyl, its presence in counterfeit pills and unregulated powders presents a serious overdose risk. A person may be exposed without knowing that the substance they purchased contains protonitazene.
Because only a very small amount may produce profound opioid effects, accurately measuring an illicit dose is extremely difficult. Variations between pills or batches can make one dose substantially stronger than another.
Understanding the dangers of protonitazene, recognizing an overdose, and seeking professional opioid addiction treatment can help prevent fatal outcomes.
What Is Protonitazene?
Protonitazene is a laboratory-made opioid in the 2-benzylbenzimidazole, or nitazene, family. Like heroin, fentanyl, oxycodone, and other opioids, it primarily activates mu-opioid receptors in the brain and body.
Activation of these receptors can produce:
- Pain relief
- Euphoria
- Sedation
- Reduced anxiety
- Slowed breathing
- Physical dependence
Protonitazene does not have an accepted medical use in the United States. As of 2026, the Drug Enforcement Administration lists it as a Schedule I controlled substance.
The substance began appearing in forensic toxicology samples in North America during the early 2020s. It has since been identified in overdose investigations, counterfeit tablets, illicit opioid powders, and products represented as other drugs.
How Strong Is Protonitazene?
Protonitazene is generally considered substantially more potent than morphine and may be more potent than fentanyl. However, exact potency estimates vary depending on the research method, formulation, route of administration, and comparison being used.
The Centers for Disease Control and Prevention has reported that laboratory findings suggest protonitazene and certain other nitazene analogs may greatly exceed fentanyl’s potency. More recent federal cases have described protonitazene as approximately three times as potent as fentanyl.
These estimates should not be interpreted as a predictable conversion. Illicitly produced protonitazene is not manufactured under controlled pharmaceutical conditions. Its concentration may vary significantly between samples, making any exposure dangerous.
Why Is Protonitazene So Dangerous?
Protonitazene presents many of the same risks as other opioids, but its potency and unpredictability may make those risks more severe.
Unintentional Exposure
Many people who experience nitazene poisoning do not knowingly take a nitazene. Protonitazene may be sold as or mixed into:
- Heroin
- Fentanyl
- Oxycodone
- Hydrocodone
- Xanax
- Other counterfeit prescription pills
- Unregulated powders
- Drugs purchased through social media or illicit websites
In a clinical study of confirmed nitazene exposures, many patients believed they had taken a different opioid or another substance entirely.
The appearance of a tablet cannot confirm its contents. Counterfeit pills may closely resemble medications produced by legitimate pharmaceutical companies.
Severe Respiratory Depression
Protonitazene can suppress the brain’s drive to breathe. Breathing may become dangerously slow, irregular, shallow, or stop completely.
Without oxygen, brain injury and death can occur within minutes. The risk increases when protonitazene is combined with other central nervous system depressants.
Unpredictable Potency
Illicit manufacturers may not distribute protonitazene evenly throughout a powder or batch of tablets. One pill may contain little of the substance while another pill from the same batch contains a lethal amount.
This uneven distribution is sometimes referred to as the “chocolate chip cookie effect.” A person cannot determine the strength of a pill based on its color, markings, size, or previous experience with pills from the same source.
Limited Routine Testing
Some standard toxicology screens do not identify protonitazene or other emerging synthetic opioids. Specialized laboratory testing may be required.
As a result, nitazene exposure may initially be recorded simply as an opioid overdose or may go unidentified altogether. Researchers have warned that conventional toxicological screening may underestimate the prevalence of protonitazene intoxication.
Signs of a Protonitazene Overdose
A protonitazene overdose will generally resemble an overdose involving fentanyl, heroin, or another opioid.
Warning signs include:
- Extremely slow, shallow, or absent breathing
- Pinpoint pupils
- Blue, gray, or pale lips and fingertips
- Unresponsiveness
- Inability to wake the person
- Choking, snoring, or gurgling sounds
- Limpness
- Vomiting
- Weak or absent pulse
- Cold or clammy skin
Unusual snoring or gurgling should not be assumed to mean that the person is sleeping. These sounds may occur when someone cannot maintain an open airway.
What to Do During a Suspected Protonitazene Overdose
Treat any suspected opioid overdose as an immediate medical emergency.
Call 911
Contact emergency services immediately. Tell the dispatcher that the person is unresponsive or not breathing normally and that an opioid overdose may have occurred.
Administer Naloxone
Naloxone, commonly known by the brand name Narcan, can temporarily reverse respiratory depression caused by opioids.
Naloxone has successfully reversed nitazene-related overdoses. However, multiple doses may sometimes be needed because of the potency of certain nitazenes.
Administer the first dose as soon as possible. When using nasal naloxone, follow the product instructions and give additional doses as directed if the person does not respond.
Do not delay calling 911 while waiting to see whether naloxone works.
Support the Person’s Breathing
Provide rescue breathing or CPR when instructed by the emergency dispatcher and when trained to do so.
If the person begins breathing but remains unconscious, place them on their side to reduce the risk of choking. Remain with them until emergency responders arrive.
Even when the person wakes up, medical evaluation remains necessary. Naloxone’s effects may wear off while the opioid is still active, allowing respiratory depression to return.
Can Fentanyl Test Strips Detect Protonitazene?
Standard fentanyl test strips are designed to detect fentanyl and certain closely related substances. They should not be relied upon to detect protonitazene or rule out the presence of other nitazenes.
A negative fentanyl test therefore does not mean that an illicit pill or powder is free from powerful synthetic opioids.
Drug-checking technology continues to develop, but no home-testing method can guarantee that an unregulated substance is safe. The safest approach is not to consume pills that did not come directly from a licensed pharmacy.
Protonitazene Side Effects
Possible short-term effects of protonitazene include:
- Euphoria
- Drowsiness
- Mental confusion
- Nausea or vomiting
- Constipation
- Itching
- Constricted pupils
- Reduced coordination
- Low blood pressure
- Slowed heart rate
- Respiratory depression
- Loss of consciousness
The effects may vary depending on the dose, route of use, individual tolerance, and the presence of other substances.
Combining protonitazene with alcohol, benzodiazepines, sedatives, sleep medications, gabapentinoids, or other opioids can greatly increase the risk of breathing problems and death.
Can Protonitazene Cause Addiction?
Yes. As a powerful opioid receptor agonist, protonitazene may produce tolerance, physical dependence, compulsive use, and opioid use disorder.
Tolerance occurs when the body becomes less responsive to a substance over time. A person may begin using larger or more frequent amounts to experience the effects they once obtained from a smaller dose.
Physical dependence means that the body has adapted to the opioid. Abruptly stopping may cause withdrawal symptoms.
Signs of an opioid use disorder may include:
- Strong cravings
- Using more than intended
- Repeated unsuccessful efforts to stop
- Spending substantial time obtaining or recovering from opioids
- Continuing despite relationship, health, legal, or financial consequences
- Giving up important responsibilities or activities
- Using in dangerous situations
- Developing tolerance
- Experiencing withdrawal
Addiction is a treatable medical condition. It does not reflect a lack of morality, motivation, or concern for loved ones.
Protonitazene Withdrawal Symptoms
Information specifically examining protonitazene withdrawal remains limited. Because it acts on opioid receptors, withdrawal is expected to resemble withdrawal from other potent opioids.
Symptoms may include:
- Anxiety
- Restlessness
- Muscle and bone pain
- Sweating
- Chills
- Runny nose
- Watery eyes
- Yawning
- Abdominal cramping
- Diarrhea
- Nausea and vomiting
- Insomnia
- Rapid heart rate
- Strong opioid cravings
Withdrawal is not usually fatal by itself in otherwise healthy adults, but complications can occur. Vomiting and diarrhea can lead to dehydration, and reduced tolerance after a period of abstinence creates a particularly high overdose risk if opioid use resumes.
Professional medical support can improve comfort, monitor complications, and connect the individual with ongoing treatment.
How Is Protonitazene Addiction Treated?
Treatment for protonitazene addiction generally follows evidence-based approaches used for other forms of opioid use disorder.
A treatment plan may include medical care, medication, counseling, behavioral support, relapse-prevention planning, and services addressing mental health or environmental needs.
Medical Detoxification
Medical detox provides monitoring and support during the initial withdrawal period. Clinicians can evaluate symptoms, manage dehydration or other complications, and determine whether medication for opioid use disorder is appropriate.
Detox alone is not considered complete addiction treatment. Continuing care is important because cravings and overdose vulnerability can persist after withdrawal symptoms improve.
Medication for Opioid Use Disorder
FDA-approved medications for opioid use disorder include:
- Buprenorphine
- Methadone
- Extended-release naltrexone
Buprenorphine and methadone reduce withdrawal symptoms and cravings by acting on opioid receptors in a controlled clinical context. Extended-release naltrexone blocks opioid receptors but can only be started after an adequate opioid-free period.
Medication selection should be individualized. A qualified healthcare provider can assess a person’s opioid exposure, withdrawal status, medical history, and treatment goals.
Residential Treatment
Residential addiction treatment provides a structured, substance-free setting with continuous support. It may be appropriate for people with severe opioid addiction, repeated overdoses, unstable living conditions, co-occurring mental health concerns, or previous unsuccessful treatment attempts.
Residential programming may incorporate:
- Individual therapy
- Group counseling
- Addiction education
- Medication management
- Relapse-prevention training
- Trauma-informed care
- Family involvement
- Wellness activities
- Discharge and aftercare planning
Behavioral Therapy
Therapeutic approaches may help individuals understand patterns associated with opioid use and develop healthier ways to respond to cravings, stress, trauma, and emotional discomfort.
Depending on the person’s needs, treatment may use:
- Cognitive behavioral therapy
- Motivational interviewing
- Contingency management
- Trauma-informed therapy
- Family therapy
- Peer recovery support
Treatment should also address co-occurring conditions such as depression, anxiety, post-traumatic stress, chronic pain, or other substance use.
Getting Help for Opioid Addiction at Phoenix Rising Recovery
The emergence of protonitazene demonstrates how rapidly the illicit opioid supply can change. People may encounter increasingly potent substances without knowing what they are taking, making continued opioid use particularly unpredictable.
Phoenix Rising Recovery provides comprehensive addiction treatment in a supportive environment. Our clinical team works with each individual to develop a personalized plan addressing opioid use, underlying mental health concerns, relapse risks, relationships, and long-term recovery goals.
Seeking treatment does not require waiting for another overdose, legal problem, or personal crisis. Early intervention can reduce risk and create a safer path forward.
Contact Phoenix Rising Recovery today to learn more about opioid addiction treatment and the appropriate level of care for you or someone you love.
Frequently Asked Questions
Is protonitazene stronger than fentanyl?
Available research and federal reports suggest that protonitazene may be more potent than fentanyl, although estimates vary. Its illicit concentration is unpredictable, so there is no reliably safe dose.
Is protonitazene the same as isotonitazene?
No. Protonitazene and isotonitazene are related synthetic opioids within the nitazene family, but they have different chemical structures. Both have been associated with severe poisoning and fatal overdoses.
Is protonitazene used medically?
No. Protonitazene has no accepted medical use in the United States and is classified as a Schedule I controlled substance.
Can Narcan reverse a protonitazene overdose?
Naloxone can reverse respiratory depression caused by nitazenes. Multiple doses may be required, and emergency medical care is still necessary.
Can protonitazene be found in counterfeit pills?
Yes. Protonitazene has been found in counterfeit tablets and may be represented as oxycodone, Xanax, or other prescription medications. Pills obtained outside licensed pharmacies should be considered potentially dangerous.
Why are nitazenes appearing in the drug supply?
Illicit manufacturers may use nitazenes because they are highly potent and can be added to powders or counterfeit tablets in small quantities. Their presence also changes as manufacturers attempt to evade regulations or replace other controlled substances.
What is protonitazepyne?
Protonitazepyne, also called N-pyrrolidino protonitazene, is a related but chemically distinct nitazene opioid. It has also been connected to severe and fatal intoxications and is separately controlled under federal law.
When should someone seek treatment?
A person should consider professional help when opioid use has become difficult to control, produces withdrawal or cravings, contributes to risky behavior, or continues despite harmful consequences. Treatment is also strongly recommended after any opioid overdose.
Sources
Center for Forensic Science Research and Education. (2021, December 10). Protonitazene: New synthetic opioid identified in the United States. https://www.cfsre.org/images/content/reports/public_alerts/2021.12.10.Public-Alert_Protonitazene_NPS-Discovery_121021.pdf
Meltzer, J., Habib, E., Selwyn, J., & Phillips, L. (2025). Accidental protonitazene intoxication: Clinical management and detection of a novel opioid. BMJ Case Reports, 18(3), e261722. https://doi.org/10.1136/bcr-2024-261722
National Center for Biotechnology Information. (2026). PubChem compound summary for CID 156589001: Protonitazene. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Protonitazene
United Nations Office on Drugs and Crime. (2024). Nitazenes. Early Warning Advisory on New Psychoactive Substances. https://www.unodc.org/LSS/substancegroup/Details/6aefe0ca-aafd-452c-a534-c16aa3a2e507
United Nations Office on Drugs and Crime. (2025, February 4). Increasing availability of nitazenes calls for global response. https://www.unodc.org/LSS/Announcement/Details/b47cf39e-f557-4001-98a8-536af5673e9e
United Nations Office on Drugs and Crime. (2025). World drug report 2025: Key findings. https://www.unodc.org/documents/data-and-analysis/WDR_2025/WDR25_B1_Key_findings.pdf
United States Department of Justice. (2024, July 18). Two charged with distribution of protonitazene, a novel synthetic opioid more potent than fentanyl. https://www.justice.gov/usao-sdny/pr/two-charged-distribution-protonitazene-novel-synthetic-opioid-more-potent-fentanyl
Verbeek, J., Vermeulen, T., De Vrieze, M., & Stove, C. P. (2025). A comprehensive narrative review of protonitazene. Journal of Clinical Medicine, 14. https://pmc.ncbi.nlm.nih.gov/articles/PMC12239055/
World Health Organization. (2022). Protonitazene: Critical review report. Expert Committee on Drug Dependence, 45th meeting. https://cdn.who.int/media/docs/default-source/controlled-substances/45th-ecdd/protonitazene_draft.pdf